Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke

Inclusion Criteria: 1. Meet the diagnostic criteria of acute intracerebral hemorrhage； 2. CT scan reveals cerebral parenchymal hemorrhage and the volume of hematoma is \<80ml; 3. The time from onset to confirmed diagnosis by CT scan is within 4 hours; 4. Enrolled and receive treatment within 12 hours from onset; 5. Age ≥18 years old; 6. Obtain approval from the patient or family members. Exclusion Criteria: 1. The time from onset to confirmed diagnosis by CT scan is over 4 hours; 2. CT scan indicate that the sites of hemorrhage are in the cerebellum, brainstem and ventricle (note: in case of cerebral parenchymal hemorrhage combined with ventricular hemorrhage, patients will be excluded if the volume of ventricular hemorrhage is the larger one); 3. The volume of hematoma is above 80ml; 4. Glasgow Coma Scale (GCS) is ≤ 5 points; 5. The time from onset to confirmed diagnosis is over 12 hours; 6. Have a surgical treatment planning within 24 hours; 7. Cerebral hemorrhage caused by trauma, arteriovenous malformation, thrombolytic therapy, anticoagulant therapy or other reasons; 8. Patients with disabilities before onset (modified mRS score \> 2); 9. Patients with severe primary diseases of the heart, lung, liver, kidney, endocrine systems or hematopoietic system; 10. Patients who have participated in other clinical trials within the past 1 month; 11. Pregnant or nursing women; 12. Allergic constitution (allergic to more than two kinds of food or medications).